Vandetanib with pemetrexed in patients with previously treated non-small cell lung cancer (NSCLC): An open-label, multicenter phase I study

被引：0

作者：

De Boer, R.

Vansteenkiste, J.

Humblet, Y.

Wolf, J.

Nogova, L.

Ruffert, K.

Smith, R.

Godwood, A.

Milenkova, T.

机构：

[1] Western Hosp, Melbourne, Vic, Australia

[2] Univ Hosp Leuven, Leuven, Belgium

[3] Univ Catholique Louvain Hosp, Brussels, Belgium

[4] Univ Hosp Cologne, Cologne, Germany

[5] Clin & Gen Practice Internal Med, Jena, Germany

[6] AstraZeneca, Macclesfield, Cheshire, England

[7] AstraZeneca, Loughborough, Leics, England

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

7654

引用

页数：2